Portal Home For reimbursement information regarding other Centocor Ortho Biotech Inc. products, please click here.
PROCRITline.com Reimbursement Excellence Centocor Ortho Biotech Inc.
Introduction Commercial Payer Prior Authorization Medicare Part D Prior Authorization Please see full Prescribing Information, including Boxed WARNINGS, for PROCRIT® (Epoetin alfa) Medicare Guideline Archives Medicare Guideline Update Table CMS 1450 / UB-04

State Medicare Guidelines / CMS 1500
Select



State Medicare Guidelines / CMS 1500

Alabama Printable Version


Summary - Part A  Summary - Part B  

National Coverage Determination

Local Coverage Determinations / Supporting Documentation:
MAC Part A - MAC Part B

CMS 1500 Examples
Initial Claims: Oncology 1 Subsequent Claims: Oncology 2
Nephrology 1 Nephrology 2
AZT/HIV 1 AZT/HIV 2
Surgery 1 Surgery 2
Payers

Part-A
Cahaba GBA

Part-B
Cahaba GBA

Carrier/FI/MAC Changes




Please refer to the National Coverage Determination (NCD) for additional information that may supercede the Medicare guidelines provided by your local Medicare Carrier, Fiscal Intermediary, or Medicare Administrative Contractor (MAC).



Summary - Part A - Updated September 01, 2010

For additional information on Medicare covered indications for your specific state, please see the appropriate Part A Local Coverage Determinations/Supporting Documentation which may be accessed through the link above or by
clicking here - Part A.

Your state has two Medicare contractors which process claims for Part A providers. If you use WPS (formerly Mutual of Omaha), please select it now. WPS If you do not use WPS, the Medicare guideline summary is below.

Indication ICD-9-CM HCPCS Starting Labs Ending Labs GFR/Serum Creatinine Allowable Dosage Post Chemo
Cancer (non-myeloid malignancies, on chemo) 284.89 or 285.22 or 285.3 and E930.7 or E933.1
Link
J0885
Link
HCT < 30% or Hb < 10%
Link
HCT 30% or Hb 10%
Link
SC: Not Applicable

GFR: Not Applicable
Per FDA
Link
8 weeks
Link
AIDS/AZT 285.29 and 042 or V08
Link
J0885
Link
HCT < 33% and symptomatic
Link
Not Stated SC: Not Applicable

GFR: Not Applicable
Per FDA
Link
Not Applicable
Renal 285.21 and 403.11, 403.91, 404.13, 404.91, 404.93, 585.3, 585.4, or 585.5
Link
J0885
Link
HCT < 33% and symptomatic
Link
HCT 36% or Hb 12 g/dL
Link
Date and result of most recent serum creatinine or GFR within the last month prior to initiation of therapy. Lab values not stated.
Link
Per FDA
Link
Not Applicable
Surgery (elective, noncardiac, nonvascular) 284.89, 285.0, 285.21, 285.22, 285.29 or 285.9 and V07.8
Link
J0885
Link
HCT between 30-39%
Link
Not Stated SC: Not Applicable

GFR: Not Applicable
Per FDA
Link
Not Applicable

These summaries have been prepared using the Medicare guidelines. If you would like to receive the Medicare guidelines, you can call PROCRITline® at 1-800-553-3851 or you can contact the Medicare contractor directly at the web address in the State Medicare Payers box above.
R146
Back to Top



Please refer to the National Coverage Determination (NCD) for additional information that may supercede the Medicare guidelines provided by your local Medicare Carrier, Fiscal Intermediary, or Medicare Administrative Contractor (MAC).



Summary - Part B - Updated September 01, 2010

For additional information on Medicare covered indications for your specific state, please see the appropriate Medicare carrier Part B Local Coverage Determinations/Supporting Documentation which may be accessed through the link above or by
clicking here - Part B.

Indication ICD-9-CM HCPCS Starting Labs Ending Labs GFR/Serum Creatinine Allowable Dosage Post Chemo
Cancer (non-myeloid malignancies, on chemo) 284.89 or 285.22 or 285.3 and E930.7 or E933.1
Link
J0885
Link
HCT < 30% or Hb < 10%
Link
HCT 30% or Hb 10%
Link
SC: Not Applicable

GFR: Not Applicable
Per FDA
Link
8 weeks
Link
AIDS/AZT 285.29 and 042 or V08
Link
J0885
Link
HCT < 33% and symptomatic
Link
Not Stated SC: Not Applicable

GFR: Not Applicable
Per FDA
Link
Not Applicable
Renal 285.21 and 403.11, 403.91, 404.13, 404.91, 404.93, 585.3, 585.4, or 585.5
Link
J0885
Link
HCT < 33% and symptomatic
Link
HCT 36% or Hb 12 g/dL
Link
Date and result of most recent serum creatinine or GFR within the last month prior to initiation of therapy. Lab values not stated.
Link
Per FDA
Link
Not Applicable
Surgery (elective, noncardiac, nonvascular) 284.89, 285.0, 285.21, 285.22, 285.29 or 285.9 and V07.8
Link
J0885
Link
HCT between 30-39%
Link
Not Stated SC: Not Applicable

GFR: Not Applicable
Per FDA
Link
Not Applicable

These summaries have been prepared using the Medicare guidelines. If you would like to receive the Medicare guidelines, you can call PROCRITline® at 1-800-553-3851 or you can contact the Medicare contractor directly at the web address in the State Medicare Payers box above.
R146
Back to Top